Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Change-To-Inventory" stands at 1.09 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 03/31/2024.
Amgen Inc's third quarter result of 0.24 Billion USD for the item "Change To Inventory" represents an increase of 0.42 percent compared to it's second quarter result.
Also, Amgen Inc's third quarter result of 0.24 Billion USD for the item "Change To Inventory" represents a decrease of -64.76 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Amgen Inc's third quarter result of 1.09 Billion USD for the item "Change To Inventory" represents a decrease of -28.80 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -1.69 Billion United States Dollars compared to the value the year prior.
The 1 year change is -1.69 Billion United States Dollars.
The 3 year change is 1.69 Billion United States Dollars.
The 5 year change is 1.37 Billion United States Dollars.
The 10 year change is 0.578 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change To Inventory | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change To Inventory | 486,508,953,600.00 |
![]() | AbbVie Inc - Change To Inventory | 399,570,305,024.00 |
![]() | Roche Holding AG - Change To Inventory | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change To Inventory | 280,205,508,085.11 |